You just read:

Liver Cancer Researchers from AP-HP and Singapore Collaborate on a Prospective Meta-Analysis of Two Studies of Y-90 resin microspheres versus Sorafenib in Patients with Unresectable Hepatocellular Carcinoma (HCC)

News provided by

Greater Paris University Hospital (AP-HP)

Oct 06, 2016, 03:00 ET